Skip to main content
. 2021 Jul 1;195(2):186–193. doi: 10.1111/bjh.17608

Fig 1.

Fig 1

Adverse events to BNT162b2 mRNA COVID‐19 vaccine reported in patients diagnosed with multiple myeloma (MM) versus healthy controls. [Colour figure can be viewed at wileyonlinelibrary.com]